Literature DB >> 476434

Serum thyroglobulin concentrations and whole-body radioiodine scan in follow-up of differentiated thyroid cancer after thyroid ablation.

S C Ng Tang Fui, R Hoffenberg, M N Maisey, E G Black.   

Abstract

Measurement of serum thyroglobulin (Tg) concentrations and whole-body radioiodine scan were performed simultaneously during follow-up of 32 patients with differentiated thyroid cancer who had undergone thyroid ablation by operation and radioiodine. Almost all patients in whom serum Tg was undetectable had normal scans. Concentrations exceeding 50 ng/ml were invariably associated with residual or metastatic tumour uptake in the scan. Out of 21 observations of detectable values below 50 ng/ml, 14 were in patients whose scans showed subclinical or sub-radiological tumour uptake and seven in patients with normal scans. The sensitivity of serum Tg as a tumour marker compared favourably to that of the whole-body scan. A scan is unnecessary when serum Tg is undetectable, but in patients with detectable serum Tg concentrations, particularly if these are below 50 ng/ml, a scan is important to assess and localise tumour uptake of iodine before advising treatmet with iodine-131.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 476434      PMCID: PMC1595682          DOI: 10.1136/bmj.2.6185.298

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  5 in total

1.  Prospects from the treatment of thyroid carcinoma with radioiodine.

Authors:  E E Pochin
Journal:  Clin Radiol       Date:  1967-04       Impact factor: 2.350

2.  Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas.

Authors:  A J Herle; R P Uller
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

3.  Radioimmunoassay for measurement of thyroglobulin in human serum.

Authors:  A J Van Herle; R P Uller; N I Matthews; J Brown
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

4.  Plasma thyroglobulin in detecting thyroid carcinoma after childhood head and neck irradiation.

Authors:  A B Schneider; M J Favus; M E Stachura; J E Arnold; U Y Ryo; S Pinsky; M Colman; M J Arnold; L A Frohman
Journal:  Ann Intern Med       Date:  1977-01       Impact factor: 25.391

5.  Serum thyroglobulin in the diagnosis and management of thyroid carcinoma.

Authors:  A H Shlossberg; J C Jacobson; H K Ibbertson
Journal:  Clin Endocrinol (Oxf)       Date:  1979-01       Impact factor: 3.478

  5 in total
  12 in total

1.  Post-operative diagnosis and therapy of thyroid carcinoma by nuclear medicine.

Authors:  H Hundeshagen
Journal:  Eur J Nucl Med       Date:  1983

2.  The value of serum thyroglobulin measurement as a marker of cancer recurrence in the follow-up of patients previously treated for differentiated thyroid tumor.

Authors:  E Roti; G Robuschi; R Emanuele; P Bandini; A Russo; P Riva; E Galassi; U P Guerra; A Manfredi; A Bozzetti; A M Guazzi; A Gnudi
Journal:  J Endocrinol Invest       Date:  1982 Jan-Feb       Impact factor: 4.256

3.  Methods of investigation in the diagnosis and management of thyroid carcinoma.

Authors:  M N Maisey
Journal:  World J Surg       Date:  1981-01       Impact factor: 3.352

4.  Cancer of the thyroid in youth.

Authors:  J A Buckwalter; N J Gurll; C G Thomas
Journal:  World J Surg       Date:  1981-01       Impact factor: 3.352

5.  Comparison of serum thyroglobulin with iodine scans in thyroid cancer.

Authors:  M A Charles
Journal:  J Endocrinol Invest       Date:  1982 Jul-Aug       Impact factor: 4.256

Review 6.  [Significance of thyroglobulin as a tumor marker in the serum of patients with differentiated thyroid carcinoma: longitudinal and cross-sectional studies (author's transl)].

Authors:  H Schatz; S Grebe; E Mäser; J Teuber; W Horn; O Schröder; C Schatz
Journal:  Klin Wochenschr       Date:  1982-05-03

7.  Immunoreactive thyroglobulin in sera and saliva of patients with various thyroid disorders: role of autoantibodies.

Authors:  A J Van Herle; P D Rosenblit; T L Van Herle; P Van Herle; M Greipel; K Kellett
Journal:  J Endocrinol Invest       Date:  1989-03       Impact factor: 4.256

8.  Scintigraphy with 201Tl for detection of thyroid cancer metastases.

Authors:  D A Piers; W J Sluiter; P H Willemse; H Doorenbos
Journal:  Eur J Nucl Med       Date:  1982

9.  Radioimmunoassay of serum thyroglobulin. Technique and clinical results.

Authors:  G Benita; F Lapalus; V Bayer; H Bornet; M Hoch
Journal:  Eur J Nucl Med       Date:  1981

10.  Predictive value of serum thyroglobulin in treated patients with differentiated thyroid carcinoma.

Authors:  D C Stephen; M S Seshadri; R Oommen; A Nair; S Swaminathan; A S Kanagasabapathy
Journal:  Indian J Clin Biochem       Date:  1999-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.